Latest Patents News

Temas Resources has confirmed its patented Regenerative Chloride Leach (RCL) technology can produce commercial-grade titanium dioxide with significant cost reductions, positioning the company for global licensing opportunities.

NOVONIX is ramping up industrial-grade synthetic graphite production with mass manufacturing slated for 2026, while battery-grade output for Panasonic faces delays until late 2027. The company also navigates a major offtake termination and secures significant funding to support its growth.

Bayan Mining and Minerals Limited has secured exclusive rights to advanced rare earth processing technologies and made significant progress on its US exploration projects, setting the stage for maiden drilling in 2026.

Adisyn Ltd has achieved a critical milestone in its pioneering low-temperature graphene deposition technology, validated by an independent expert, positioning the company for potential semiconductor industry integration.

Mandrake Resources advances its Utah Lithium Project with a significant 3.3Mt lithium carbonate equivalent inferred resource, alongside key agreements for lithium offtake and uranium recovery.

Patrys Limited has acquired Reliis, gaining a promising injectable formulation of quetiapine aimed at treating delirium with a rapid FDA approval pathway. This move positions Patrys at the forefront of addressing a significant unmet medical need in critical care.

Volt Resources has made significant strides in its US graphite refinery project and secured major funding for its Bunyu Graphite Mine in Tanzania, positioning itself strongly in the critical minerals sector.

Environmental Clean Technologies Limited has completed the acquisition of Terrajoule, gaining exclusive rights to a cutting-edge soil remediation technology targeting PFAS contamination. The company also bolstered its leadership and funding to accelerate commercialisation.

Singular Health Group has advanced its U.S. commercial footprint with the deployment of 500 new licences under its PNS contract and secured FDA clearance for its cloud-based 3DICOM MD® platform, positioning the company for significant growth.

Ionic Rare Earths’ UK subsidiary has received a £12 million capital grant offer from the UK Government to develop a pioneering rare earth magnet recycling facility in Belfast, aiming to bolster the UK’s sustainable supply chain for critical minerals.

Temas Resources has appointed Nic Matich as a Non-Executive Director to spearhead Australian investor relations and business development, while CFO David Robinson transitions to a full-time executive role to sharpen financial oversight amid the company’s growth and commercialisation push.

Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.